These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. Remuzzi A, Perico N, Amuchastegui CS, Malanchini B, Mazerska M, Battaglia C, Bertani T, Remuzzi G. J Am Soc Nephrol; 1993 Jul; 4(1):40-9. PubMed ID: 8400068 [Abstract] [Full Text] [Related]
25. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats. Volpini RA, da Silva CG, Costa RS, Coimbra TM. Diabetes Metab Res Rev; 2003 Jul; 19(1):43-51. PubMed ID: 12592643 [Abstract] [Full Text] [Related]
27. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage. Perico N, Amuchastegui CS, Malanchini B, Bertani T, Remuzzi G. Exp Nephrol; 1994 Jul; 2(4):220-8. PubMed ID: 8069658 [Abstract] [Full Text] [Related]
28. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition. Sassy-Prigent C, Heudes D, Jouquey S, Auberval D, Belair MF, Michel O, Hamon G, Bariety J, Bruneval P. Lab Invest; 1995 Jul; 73(1):64-71. PubMed ID: 7603042 [Abstract] [Full Text] [Related]
29. Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes. Moriyama T, Oka K, Ueda H, Imai E. Clin Exp Nephrol; 2004 Sep; 8(3):230-6. PubMed ID: 15480900 [Abstract] [Full Text] [Related]
30. Progression of early phase diabetic nephropathy in streptozotocin-induced diabetic rats: evaluation of various kidney-related parameters. Kiran G, Nandini CD, Ramesh HP, Salimath PV. Indian J Exp Biol; 2012 Feb; 50(2):133-40. PubMed ID: 22670476 [Abstract] [Full Text] [Related]
31. Angiotensin II binding to renal glomeruli from sodium-loaded and sodium-depleted rats. Beaufils M, Sraer J, Lepreux C, Ardaillou R. Am J Physiol; 1976 May; 230(5):1187-93. PubMed ID: 179329 [Abstract] [Full Text] [Related]
36. Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats. Xu XX, Zhang W, Zhang P, Qi XM, Wu YG, Shen JJ. Phytomedicine; 2013 Jul 15; 20(10):820-7. PubMed ID: 23664882 [Abstract] [Full Text] [Related]
37. Diabetic nephropathy in the rat: differing renal effects of an angiotensin converting enzyme inhibitor and a calcium inhibitor. Whitty MR, Jackson B. Diabetes Res; 1988 Jun 15; 8(2):91-6. PubMed ID: 2852570 [Abstract] [Full Text] [Related]
39. Automated image analysis of a glomerular injury marker desmin in spontaneously diabetic Torii rats treated with losartan. Kakimoto T, Okada K, Hirohashi Y, Relator R, Kawai M, Iguchi T, Fujitaka K, Nishio M, Kato T, Fukunari A, Utsumi H. J Endocrinol; 2014 Jul 15; 222(1):43-51. PubMed ID: 24781258 [Abstract] [Full Text] [Related]
40. [The preliminary studies on the cross action between endothelin-1 and angiotensin II in kidney tissue of rats with diabetic nephropathy]. Cheng H, Tian XF, Dong HR, Ding SS, Qiu CB, Chen YP. Zhonghua Yi Xue Za Zhi; 2004 Feb 02; 84(3):248-52. PubMed ID: 15059549 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]